Elitek (rasburicase)
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
June 2016
BOX WARNING
Change 1st section of Anaphylaxis to read:
Hypersensitivity Reactions: Elitek can cause serious and fatal...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts